Clinical Trial Update: Effects of PA-1 Transcriptional Regulation on Monocyte Function

View source ↗

Summary

A Vanderbilt-led clinical trial evaluating PA-1 transcriptional regulation and monocyte function in atherosclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Vanderbilt University | Conditions: Atherosclerosis | Status: TERMINATED